Clinicopathological Evaluation of Terminal Ileal Nodular Lymphoid Hyperplasia in Adults: A Single-Center Experience
- 1Department of Gastroenterology, University of Health Sciences Diyarbakır Gazi Yaşargil Training and Research Hospital, 21070 Diyarbakır, Turkey
- 2Department of Pathology, University of Health Sciences Diyarbakır Gazi Yaşargil Training and Research Hospital, 21070 Diyarbakır, Turkey
Abstract
Background/Objectives: Terminal ileal nodular lymphoid hyperplasia (NLH) can mimic Crohn’s disease endoscopically, and data integrating its clinical, laboratory, endoscopic, and histopathological features in adults are limited. We aimed to describe these features and associated conditions. Methods: This retrospective single-center study included adults who underwent colonoscopy between January 2023 and December 2025 with terminal ileal biopsy for endoscopically suspected NLH; histopathological confirmation was required for inclusion. Giardia lamblia (G. lamblia)–positive and –negative patients were compared as a secondary exploratory analysis. Results: Histology confirmed NLH in 50 of 64 biopsied patients (78.1%); 43 with essential inclusion data were analyzed (mean age 35.1 ± 12.0 years; 67.4% male); fecal calprotectin was available in 40. Diarrhea and abdominal pain were leading indications. Findings were predominantly reactive, with no morphological features of lymphoma; one patient with Crohn’s-suggestive features was subsequently diagnosed with Crohn’s disease. No patient had hypogammaglobulinemia or positive celiac serology. G. lamblia infection (10/43, 23.3%) was associated with higher fecal calprotectin (median 36.5 vs. 9.0 µg/g; p = 0.016). Conclusions: On routine histology, adult terminal ileal NLH appears predominantly benign and reactive; however, endoscopic appearance alone was insufficient for diagnosis in one fifth of cases. The G. lamblia–calprotectin association is exploratory and requires confirmation.
Related
- Cutaneous B-cell lymphoid hyperplasia successfully treated with oral abrocitinib: A case report.
- PANCREATIC NEUROENDOCRINE TUMORS: CLINICOPATHOLOGICAL ANALYSIS AND POSTOPERATIVE SURVIVAL FOLLOWING SURGICAL RESECTION-A DECADE OF EXPERIENCE AT A TERTIARY UNIVERSITY HOSPITAL.
- Real-World Clinicopathological Characteristics, Metastatic Distribution, and Treatment Patterns of Triple-Negative Breast Cancer: A Single-Institution Experience from Nigeria
- Evaluation of Clinicopathological and Radiological Parameters in Predicting the Difficulty of Laparoscopic Cholecystectomy
- Evaluation of a colorectal cancer screening program composed of successive waves of different tests: The experience of the French Calvados County
BibTeX
@article{karabulut2026clinicopathological,
title = {{Clinicopathological Evaluation of Terminal Ileal Nodular Lymphoid Hyperplasia in Adults: A Single-Center Experience}},
author = {Ümit Karabulut and Ahmet Yavuz and Çiğdem Budak Ece and Pınar Ergen},
journal = {Journal of Clinical Medicine},
year = {2026},
month = nov,
doi = {10.3390/jcm15218761},
url = {https://www.mdpi.com/2077-0383/15/21/8761},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Clinicopathological Evaluation of Terminal Ileal Nodular Lymphoid Hyperplasia in Adults: A Single-Center Experience
AU - Ümit Karabulut
AU - Ahmet Yavuz
AU - Çiğdem Budak Ece
AU - Pınar Ergen
PY - 2026
DA - 2026/11/09
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218761
UR - https://www.mdpi.com/2077-0383/15/21/8761
AB - Background/Objectives: Terminal ileal nodular lymphoid hyperplasia (NLH) can mimic Crohn’s disease endoscopically, and data integrating its clinical, laboratory, endoscopic, and histopathological features in adults are limited. We aimed to describe these features and associated conditions. Methods: This retrospective single-center study included adults who underwent colonoscopy between January 2023 and December 2025 with terminal ileal biopsy for endoscopically suspected NLH; histopathological confirmation was required for inclusion. Giardia lamblia (G. lamblia)–positive and –negative patients were compared as a secondary exploratory analysis. Results: Histology confirmed NLH in 50 of 64 biopsied patients (78.1%); 43 with essential inclusion data were analyzed (mean age 35.1 ± 12.0 years; 67.4% male); fecal calprotectin was available in 40. Diarrhea and abdominal pain were leading indications. Findings were predominantly reactive, with no morphological features of lymphoma; one patient with Crohn’s-suggestive features was subsequently diagnosed with Crohn’s disease. No patient had hypogammaglobulinemia or positive celiac serology. G. lamblia infection (10/43, 23.3%) was associated with higher fecal calprotectin (median 36.5 vs. 9.0 µg/g; p = 0.016). Conclusions: On routine histology, adult terminal ileal NLH appears predominantly benign and reactive; however, endoscopic appearance alone was insufficient for diagnosis in one fifth of cases. The G. lamblia–calprotectin association is exploratory and requires confirmation.
SN - 2077-0383
ER -